A new study has revealed that taking aspirin increases the risk of heart failure by 26 percent. Several other factors, such as smoking, obesity, high blood pressure, cholesterol, diabetes and cardiovascular diseases, contribute to increased risk of heart failure.
The new research has been published in the ‘ESC Heart Failure Journal’. “This is the first study to report that among individuals with at least one risk factor for heart failure, those taking aspirin were more likely to subsequently develop the condition than those not using the medication,” the study’s author Dr Blerim Mujaj of the University of Freiburg, Germany told ANI.
“While the findings require confirmation, they do indicate that the potential link between aspirin and heart failure needs to be clarified,” Mujaj added.
The studies conducted on the influence of aspirin on heart failure have led to controversial discussions and findings. This research came to its conclusion by evaluating the effects of aspirin and its relationship with heart failure incidents in those who have heart disease and well as those who do not.
An assessment was conducted which concluded whether or not the drug can lead to a new diagnosis of heart failure in those who were already at risk.
Individuals at risk are defined as those who suffer from obesity, high blood pressure, high cholesterol, diabetes, cardiovascular disease and smokers. In all, 30,827 individuals belonging to Western Europe and the United States were analysed for the study. These people were over 40 years of age and free of the risk of heart failure at baseline.
The usage of aspiring was tracked by classifying participants into users and non-users.
The average age of participants was 67 years and 34 per cent were women. At baseline, a total of 7,698 participants (25 percent) were taking aspirin. During the 5.3-year follow-up, 1,330 participants had developed heart failure. The large scale research was analysed using several different methods and the conclusion was that taking aspirin can lead to 26 percent raised risk of developing a new heart failure diagnosis.
“Large multinational randomised trials in adults at risk for heart failure are needed to verify these results. Until then, our observations suggest that aspirin should be prescribed with caution in those with heart failure or with risk factors for the condition,” Mujaj concluded by saying.